Roubaix Capital LLC bought a new position in Arteris, Inc. (NASDAQ:AIP – Free Report) in the third quarter, Holdings Channel.com reports. The firm bought 233,726 shares of the company’s stock, valued at approximately $2,361,000.
Other hedge funds also recently made changes to their positions in the company. Strs Ohio increased its position in Arteris by 16.5% during the 3rd quarter. Strs Ohio now owns 20,500 shares of the company’s stock worth $207,000 after purchasing an additional 2,900 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Arteris in the second quarter valued at approximately $32,000. Bank of America Corp DE grew its stake in shares of Arteris by 11.8% during the second quarter. Bank of America Corp DE now owns 57,093 shares of the company’s stock worth $544,000 after buying an additional 6,008 shares during the last quarter. Essex Investment Management Co. LLC grew its stake in shares of Arteris by 3.6% during the third quarter. Essex Investment Management Co. LLC now owns 292,159 shares of the company’s stock worth $2,951,000 after buying an additional 10,156 shares during the last quarter. Finally, Savant Capital LLC acquired a new position in shares of Arteris during the second quarter worth $97,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the company. Northland Securities set a $24.00 price objective on Arteris in a report on Friday, February 13th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a report on Wednesday, January 21st. TD Cowen reiterated a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $20.00 target price on shares of Arteris in a research report on Friday, February 13th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $20.17.
Arteris Price Performance
Shares of AIP opened at $17.02 on Tuesday. The business has a 50-day moving average of $15.89 and a 200-day moving average of $13.75. The company has a market capitalization of $773.90 million, a price-to-earnings ratio of -20.76 and a beta of 1.45. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $19.85.
Arteris (NASDAQ:AIP – Get Free Report) last announced its earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The company had revenue of $20.14 million during the quarter, compared to the consensus estimate of $18.55 million. As a group, sell-side analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.
Insider Activity
In related news, Director Saiyed Atiq Raza sold 11,762 shares of Arteris stock in a transaction on Friday, February 27th. The shares were sold at an average price of $17.01, for a total transaction of $200,071.62. Following the completion of the transaction, the director owned 499,721 shares of the company’s stock, valued at $8,500,254.21. This trade represents a 2.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Bayview Legacy, Llc sold 2,756 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $15.03, for a total transaction of $41,422.68. Following the sale, the insider directly owned 9,349,071 shares in the company, valued at $140,516,537.13. This trade represents a 0.03% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 771,797 shares of company stock valued at $12,961,426. 33.70% of the stock is owned by corporate insiders.
Arteris Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Recommended Stories
- Five stocks we like better than Arteris
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP – Free Report).
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
